Six year follow-up after CSII initiation: HbA1c is significantly reduced without weight gain

被引：0
|
作者：
Andersen, H. U. [1 ]
Hangaard, S. [1 ]
Hommel, E. E. [1 ]
Ridderstrale, M. [1 ]
机构：
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
193
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [41] Physiological Predictors of Weight Regain at 1-Year Follow-Up in Weight-Reduced Adults with Obesity
    Nymo, Siren
    Coutinho, Silvia R.
    Rehfeld, Jens F.
    Truby, Helen
    Kulseng, Bard
    Martins, Catia
    OBESITY, 2019, 27 (06) : 925 - 931
  • [42] Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up
    Wilding, J.
    Bailey, C.
    Rigney, U.
    Blak, B.
    Kok, M.
    Emmas, C.
    PRIMARY CARE DIABETES, 2017, 11 (05) : 437 - 444
  • [43] Dapagliflozin therapy for Type 2 diabetes in primary care: effects on HbA1c, weight and blood pressure over two years follow-up
    Wilding, J.
    Bailey, C.
    Rigney, U.
    Blak, B.
    Kok, M.
    Emmas, C.
    DIABETIC MEDICINE, 2017, 34 : 189 - 189
  • [44] Weight gain up to midlife and development of diabetes during a 27-year follow-up
    Strandberg, TE
    Strandberg, AY
    Salomaa, V
    Pitkala, KH
    Miettinen, TA
    CIRCULATION, 2005, 111 (14) : E201 - E201
  • [45] 2-Year Follow-up: Association of Peripheral Arterial Disease, Albuminuria, Dyslipidemia with HbA1c in T2DM Patients
    Rohatgi, R.
    Kudkar, P.
    Alfred, D.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [46] Sotagliflozin further improves percentage of patients achieving HbA1c goal without weight gain in adults with type 1 diabetes after insulin therapy optimisation
    Henry, R.
    Rodbard, H.
    Giaccari, A.
    Lajara, R.
    Stewart, J.
    Strumph, P.
    Oliveira, J.
    Lapuerta, P.
    Castro, R.
    DIABETOLOGIA, 2018, 61 : S297 - S297
  • [47] Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany
    Heinemann, Lutz
    Kaiser, Patricia
    Freckmann, Guido
    Grote-Koska, Denis
    Kerner, Wolfgang
    Landgraf, Ruediger
    Merker, Ludwig
    Mueller, Ulrich A.
    Mueller-Wieland, Dirk
    Roth, Johannes
    Spannagl, Michael
    Wallaschofski, Henri
    Nauck, Matthias
    HORMONE AND METABOLIC RESEARCH, 2018, 50 (10) : 728 - 734
  • [48] C-peptide immunoreactivity index is associated with improvement of HbA1c: 2-Year follow-up of sitagliptin use in patients with type 2 diabetes
    Nishimura, Takeshi
    Meguro, Shu
    Sekioka, Risa
    Tanaka, Karin
    Saisho, Yoshifumi
    Irie, Junichiro
    Tanaka, Masami
    Kawai, Toshihide
    Itoh, Hiroshi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (03) : 441 - 447
  • [49] Improved HbA1c and reduced glycaemic variability after 1-year intermittent use of flash glucose monitoring
    Wenhui Zhang
    Yu Liu
    Baosheng Sun
    Yanjun Shen
    Ming Li
    Lanbo Peng
    Honggang Duan
    Xudong Su
    Shaoxia Lu
    Xiaoqin Tian
    Yaqiang Tian
    Scientific Reports, 11
  • [50] Improved HbA1c and reduced glycaemic variability after 1-year intermittent use of flash glucose monitoring
    Zhang, Wenhui
    Liu, Yu
    Sun, Baosheng
    Shen, Yanjun
    Li, Ming
    Peng, Lanbo
    Duan, Honggang
    Su, Xudong
    Lu, Shaoxia
    Tian, Xiaoqin
    Tian, Yaqiang
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345